27 related articles for article (PubMed ID: 1452215)
1. Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Maleno I; López-Nevot MA; Cabrera T; Salinero J; Garrido F
Cancer Immunol Immunother; 2002 Sep; 51(7):389-96. PubMed ID: 12192539
[TBL] [Abstract][Full Text] [Related]
2. Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation.
Brunnberg J; Barends M; Frühschulz S; Winter C; Battin C; de Wet B; Cole DK; Steinberger P; Tampé R
Proc Natl Acad Sci U S A; 2024 May; 121(22):e2321600121. PubMed ID: 38771881
[TBL] [Abstract][Full Text] [Related]
3. The Immune Microenvironment in Basal Cell Carcinoma.
Zilberg C; Lyons JG; Gupta R; Damian DL
Ann Dermatol; 2023 Aug; 35(4):243-255. PubMed ID: 37550225
[TBL] [Abstract][Full Text] [Related]
4. MHC heterogeneity and response of metastases to immunotherapy.
Algarra I; Garrido F; Garcia-Lora AM
Cancer Metastasis Rev; 2021 Jun; 40(2):501-517. PubMed ID: 33860434
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade.
Lipson EJ; Lilo MT; Ogurtsova A; Esandrio J; Xu H; Brothers P; Schollenberger M; Sharfman WH; Taube JM
J Immunother Cancer; 2017; 5():23. PubMed ID: 28344809
[TBL] [Abstract][Full Text] [Related]
6. Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells.
Vineretsky KA; Karagas MR; Christensen BC; Kuriger-Laber JK; Perry AE; Storm CA; Nelson HH
Cancer Res; 2016 Jan; 76(2):370-6. PubMed ID: 26744525
[TBL] [Abstract][Full Text] [Related]
7. From cellular senescence to age-associated diseases: the miRNA connection.
Schraml E; Grillari J
Longev Healthspan; 2012 Dec; 1(1):10. PubMed ID: 24472232
[TBL] [Abstract][Full Text] [Related]
8. Secretion of microvesicular miRNAs in cellular and organismal aging.
Weilner S; Schraml E; Redl H; Grillari-Voglauer R; Grillari J
Exp Gerontol; 2013 Jul; 48(7):626-33. PubMed ID: 23283304
[TBL] [Abstract][Full Text] [Related]
9. Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma.
Rockett JC; Darnton SJ; Crocker J; Matthews HR; Morris AG
J Clin Pathol; 1995 Jun; 48(6):539-44. PubMed ID: 7665697
[TBL] [Abstract][Full Text] [Related]
10. MHC expression on human tumors--its relevance for local tumor growth and metastasis.
Garrido F; Ruiz-Cabello F
Semin Cancer Biol; 1991 Feb; 2(1):3-10. PubMed ID: 1912516
[TBL] [Abstract][Full Text] [Related]
11. HLA and skin cancer.
Bonamigo RR; Carvalho AV; Sebastiani VR; Silva CM; Pinto AC
An Bras Dermatol; 2012; 87(1):9-16; quiz 17-8. PubMed ID: 22481646
[TBL] [Abstract][Full Text] [Related]
12. HLA molecules in basal cell carcinoma of the skin.
Cabrera T; Garrido V; Concha A; Martín J; Esquivias J; Oliva MR; Ruiz-Cabello F; Serrano S; Garrido F
Immunobiology; 1992 Sep; 185(5):440-52. PubMed ID: 1452215
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigens and multiple basal cell carcinomas.
Rompel R; Petres J; Kaupert K; Müller-Eckhardt G
Recent Results Cancer Res; 1995; 139():297-302. PubMed ID: 7597298
[TBL] [Abstract][Full Text] [Related]
14. HLA and multiple skin carcinomas.
Cerimele D; Contu L; Carcassi C; Costa G; La Nasa G; Sanna E; Campus GV
Dermatologica; 1988; 176(4):176-81. PubMed ID: 3378654
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside, adhesion molecule, and HLA antigen expression in basal cell carcinoma lesions.
Kageshita T; Ono T; Hirai S; Yoshii A; Kimura T; Nakakuma H; Horikawa K; Takatsuki K; Ferrone S
Cancer Res; 1992 Jun; 52(11):3201-7. PubMed ID: 1350511
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
